Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer

Journal of Clinical Oncology

Volumn 27, Issue 12, 2009, Pages 2059-2065

  Cesaro, Simone ^a,c   Tridello, Gloria ^b   Cavaliere, Mara ^c   Magagna, Laura ^d   Gavin, Patrizia ^e   Cusinato, Riccardo ^c   Zadra, Nicola ^a   Zanon, Giovanni Franco ^a   Zanesco, Luigi ^a   Carli, Modesto ^a  

^a Clinic of Pediatric Oncology Hematology   (Italy)

^b Pediatric Surgery   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Department of Histology   (Italy)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; SODIUM CHLORIDE;

ADOLESCENT; ARTICLE; BACTEREMIA; CANCER PATIENT; CANCER SURVIVAL; CATHETER; CATHETER CARE; CATHETER FLUSHING; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER REMOVAL; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNGEMIA; HAZARD ASSESSMENT; HUMAN; INCIDENCE; INFANT; INTERMETHOD COMPARISON; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VEIN OCCLUSION;

ADOLESCENT; ANTICOAGULANTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HEPARIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; PROSPECTIVE STUDIES; SODIUM CHLORIDE; SURVIVAL RATE; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 65349196160     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.4860     Document Type: Article

References (34)

1. Raaf JH: Administration of chemotherapeutic agents. Techniques and controversies. Support Care Cancer 2:335-346, 1994
2. Freytes CO: Indications and complications of intravenous devices for chemotherapy. Curr Opin Oncol 12:303-307, 2000
3. Bishop L, Dougherty L, Bodenham A, et al: Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol 29:261-278, 2007
4. Fatkenheuer G, Cornely O, Seifert H: Clinical management of catheter-related infections. Clin Microbiol Infect 8:545-550, 2002
5. Mermel LA, Farr BM, Sherertz RJ, et al: Guidelines for the management of intravascular cathetere-related infections. Clin Infect Dis 32:1249- 1272, 2001
6. Simon A, Bode U, Beutel K: Diagnosis and treatment of catheter-related infections in paediatric oncology: An update. Clin Microbiol Infect 12:606- 620, 2006
7. Saint S, Veenstra DL, Lipsky BA: The clinical and economic consequences of nosocomial central venous catheter-related infection: Are antimicrobial catheters useful? Infect Control Hosp Epidemiol 21:375-380, 2000
8. Raad I, Hanna H, Maki D: Intravascular catheter-related infections: Advances in diagnosis, prevention, and management. Lancet Infect Dis 7:645-657, 2007
9. Mayo DJ, Cullinane AM, Marryman PK, et al: Serologic evidence of heparin sensitization in cancer patients receiving heparin flushes of venous access devices. Support Care Cancer 7:425-427, 1999
10. Jacobs BR, Schilling S, Doellman D, et al: Central venous catheter occlusion: A prospective, controlled trial examining the impact of a positivepressure valve device. JPEN J Parenter Enteral Nutr 28:113-118, 2004
11. Rummel MA, Donnelly PJ, Fortenbaugh CC: Clinical evaluation of a positive pressure device to prevent central venous catheter occlusion: Results of a pilot study. Clin J Oncol Nurs 5:261-265, 2001
12. Schilling S, Doellman D, Hutchinson N, et al: The impact of needleless connector device design on central venous catheter occlusion in children: A prospective, controlled trial. JPEN J Parenter Enteral Nutr 30:85-90, 2006
13. Cesaro S, Corrò R, Pelosin A, et al: A prospective survey on incidence and outcome of Broviac/ Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 83:183-188, 2004
14. Cesaro S, Cavaliere M, Spiller M, et al: A simplified method of antibiotic lock therapy for Broviac-Hickman catheters using a CLC 2000 connector device. Support Care Cancer 15:95-99, 2007
15. Journeycake JM, Buchanan GR: Catheterrelated deep venous thrombosis and other catheter complications in children with cancer. J Clin Oncol 24:4575-4580, 2006
16. Winthrop AL, Wesson DE: Urokinase in the treatment of occluded central venous catheter in children. J Pediatr Surg 19:536-538, 1984
17. Haire WD, Atkinson JB, Stephens LC, et al: Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blinded, randomized trial. Thromb Haemost 72:543-547, 1994
18. Wickham R, Purl S, Welker D: Long-term central venous catheters: Issues for care. Semin Oncol Nurs 8:133-147, 1992
19. Luciani A, Clement O, Halimi P, et al: Catheter-related upper extremity deep venous thrombosis in cancer patients: A prospective study based on Doppler US. Radiology 220:655-660, 2001
20. Lee AY, Levine MN, Butler G, et al: Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 24:1404-1408, 2006
21. Andrew M, Michelson AD, Bovill E, et al: Guidelines for antithrombotic therapy in pediatric patients. J Pediatr 132:575-588, 1998
22. Fratino G, Molinari AC, Parodi S, et al: Central venous catheter-related complications in chidren with oncological/hematological diseases: An observational study of 418 devices. Ann Oncol 16:648- 654, 2005
23. Ogrady NP, Alexander M, Dellinger EP, et al: Guidelines for the prevention of intravascular catheter-related infection. Am J Infect Control 30: 476-489, 2002
24. Program in Evidence Based Care: A Cancer Care Ontario Program. Managing central venous access devices in cancer patients: A clinical practice guideline. http://www.cancercare.on.ca/pdf/pebc16- 1f.pdf
25. van Rooden CJ, Schippers EF, Barge RM, et al: Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology paients: A prospective study. J Clin Oncol 23:2655-2660, 2005
26. Smith S, Dawson S, Hennessey R, et al: Maintenance of the patency of indwelling central venous catheters: Is heparin necessary? Am J Pediatr Hematol Oncol 13:141-143, 1991
27. Pierce CM, Wade A, Mok Q: Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 26:967-972, 2000
28. Dillon PW, Jones GR, Bagnali-Reeb HA, et al: Prophylactic urokinase in the management of longterm venous access devices in children: A Children's Oncology Group study. J Clin Oncol 22:2718-2723, 2004
29. van Rooden CJ, Schippers EF, Guiot HF, et al: Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: A randomized double-blind controlled trial in patients with hematologic malignancies. J Clin Oncol 26:428-433, 2008
30. Maragakis LL, Bradley KL, Song X, et al: Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 27:67-70, 2006
31. Rupp ME, Sholtz LA, Jourdan DR, et al: Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis 44:1408-1414, 2007
32. Randolph AG, Cook DJ, Gonzales CA, et al: Benefit of heparin in central venous and pulmonary artery catheters: A meta-analysis of randomized controlled trials. Chest 113:165-171, 1998
33. Cogliati AA, Dell'Utri D, Picardi A, et al: Central venous catheterization in pediatric patients affected by hematological malignancies. Haematologica 80: 448-450, 1995
34. Das I, Philpott C, George RH: Central venous catheter-related septicaemia in paediatric cancer patients. J Hosp Infect 36:67-76, 1997